| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |